Sanofi Stock Quote SNW - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

91.75

Bid

91.78

Ask

91.79

Volume

4,148

90.69 Day's Range 92.25

84.94 52 Week Range 106.12

Market Cap

114.93B

Previous Close

91.19

Open

91.01

Last Trade

383

91.75

Last Trade Time

11:10:02

Financial Volume

VWAP

Average Volume (3m)

5,564

Shares Outstanding

1,252,640,466

Dividend Yield

4.10%

PE Ratio

21.29

Earnings Per Share (EPS)

4.31

Revenue

43.07B

Net Profit

5.4B

Sector

Health & Allied Services,nec

Industry

Pharmaceutical Preparations

Website

www.sanofi.com

Headquarters

Paris, Paris, Fra

Founded

1994

Sanofi is listed in the Health & Allied Services sector of the Tradegate (DE) with ticker SNW. The last closing price for Sanofi was 91.19 €. Over the last year, Sanofi shares have traded in a share price range of 84.94 € to 106.12 €.

Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 114.23 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.29.

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Sanofi initiates phase 3 program for...

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins pneumococciques conjugués

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins...

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Paris, le 19 décembre 2024. Le Conseil...

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to...

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de...

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Duvakitug positive phase 2b results demonstrate best-in-class...

Press Release: Availability of the Q4 2024 Aide-mémoire

Press Release: Availability of the Q4 2024 Aide-mémoire Availability of the Q4 2024 Aide-mémoire Paris, France – December 17, 2024. Sanofi announced today that its Q4 2024 Aide-mémoire is...

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire »

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » Mise en ligne du document « Q4 2024 Aide-mémoire » Paris, France, le 17 Décembre 2024. Sanofi annonce la mise en ligne...

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Tolebrutinib designated Breakthrough Therapy by the FDA for...

Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées

Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées Le...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.76	1.95577286365	89.99	94.31	87.64	9781	91.30326865	DE
4	-1.17	-1.2591476539	92.92	94.31	87.64	6733	91.28271591	DE
12	-10.01	-9.83687106918	101.76	104.5	87.64	5564	94.6327344	DE
26	3.24	3.66060332166	88.51	106.12	87.64	5528	96.38537182	DE
52	3.1	3.49689791314	88.65	106.12	84.94	6044	92.78120236	DE
156	3.77	4.28506478745	87.98	106.46	76.52	5176	92.11260575	DE
260	0.54	0.592040346453	91.21	106.46	67.79	8129	87.35027754	DE

SNW - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?

The current share price of Sanofi is 91.75 €

How many Sanofi shares are in issue?

Sanofi has 1,252,640,466 shares in issue

What is the market cap of Sanofi?

The market capitalisation of Sanofi is EUR 114.23B

What is the 1 year trading range for Sanofi share price?

Sanofi has traded in the range of 84.94 € to 106.12 € during the past year

What is the PE ratio of Sanofi?

The price to earnings ratio of Sanofi is 21.29

What is the cash to sales ratio of Sanofi?

The cash to sales ratio of Sanofi is 2.67

What is the reporting currency for Sanofi?

Sanofi reports financial results in EUR

What is the latest annual turnover for Sanofi?

The latest annual turnover of Sanofi is EUR 43.07B

What is the latest annual profit for Sanofi?

The latest annual profit of Sanofi is EUR 5.4B

What is the registered address of Sanofi?

The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017

What is the Sanofi website address?

The website address for Sanofi is www.sanofi.com

Which industry sector does Sanofi operate in?

Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
0RARAPT Therapeutics Inc	1.50 € (87.50%)	65.34k
FWR0Yumy Candy Company Inc the	0.044 € (76.00%)	1.88M
4APApollo Minerals Ltd	0.01 € (66.67%)	30
NL8Genesis Ai Corp	0.0394 € (47.01%)	223.98k
E3O1Nexoptic Technology Corp	0.026 € (40.54%)	2.84k
WWTWater Ways Technologies Inc	0.0045 € (-95.91%)	2.53k
L7C2Windfall Geotek Inc	0.0025 € (-70.59%)	40k
QP9Atco Mining Inc	0.003 € (-55.88%)	1.5k
AWY0Percheron Therapeutics Ltd	0.002 € (-55.56%)	155k
0PV2Moovly Media Inc	0.002 € (-55.56%)	500
D7GNel ASA	0.2469 € (-1.87%)	2.63M
FWR0Yumy Candy Company Inc the	0.044 € (76.00%)	1.88M
DI6Distribuidora Internacional De Alimentacion SA	0.017 € (1.80%)	1.83M
JSISamhallsbyggnadsbolaget Norden AB	0.386 € (8.46%)	1.79M
RQ0DWave Quantum Inc	7.53 € (18.32%)	1.62M